In order to prevent spam,
this email address cannot be copied.
Schizophrenia Research Forum: Researcher Profile - Keith Nuechterlein
Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Researcher Profile - Keith Nuechterlein

First Name:Keith
Last Name:Nuechterlein
Advanced Degrees:Ph.D.
Department:Psychiatry and Psychology
Street Address 1:Semel Institute for Neuroscience & Human Behavior
Street Address 2:300 UCLA Medical Plaza, Room 2240
City:Los Angeles
Zip/Postal Code:90095-6968
Phone:(310) 825-0036
Fax:(310) 206-3651
Email Address:
(view policy) 
Member reports the following financial or other potential conflicts of interest: [Last Modified: 19 September 2007]

Research grant from Janssen L.P.
Past lecture honoraria from Pfizer, Bristol Myers Squibb, and Janssen-Cilag
View all comments by Keith Nuechterlein
Clinical Interests:
Research Focus:
Brain imaging, Neurodevelopment, Clinical trials, Pharmacology, Electrophysiology, Phenomenology/diagnosis, Genetics, Cognition
Work Sector(s):
Web Sites:
Reasearcher Bio
Keith H. Nuechterlein, Ph.D., is a Professor in the Departments of Psychiatry and Biobehavioral Sciences and of Psychology at the University of California, Los Angeles. He serves as the Director of the UCLA Center for Neurocognition and Emotion in Schizophrenia and the Director of the UCLA Aftercare Research Program, a research clinic devoted to research and treatment with patients who have had a recent onset of schizophrenia. Dr. Nuechterlein received his B.A. in psychology and his Ph.D. in Psychology (Clinical) from the University of Minnesota. Dr. Nuechterlein has authored more than 150 journal articles and is among the scientists on the ISI Web of Knowledge Highly Cited list for Psychology/Psychiatry. He has been on the editorial boards of the Journal of Abnormal Psychology and Schizophrenia Bulletin and is currently on the editorial board of Psychological Medicine. He has received numerous research grants from NIMH and other sources. One of his primary research programs involves multidisciplinary longitudinal studies of contributors to the early course of schizophrenia, with particular emphasis on neurocognitive determinants of functional outcome and on new interventions to improve work recovery. Another major interest is research with biological relatives of schizophrenia patients that seeks to delineate the nature of neurocognitive factors in genetic vulnerability to schizophrenia and related disorders. Dr. Nuechterlein served as the Co-Chair of the Neurocognition Committee for the recent NIMH-funded initiative, Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS). This group had the responsibility for overseeing the development of the MATRICS Consensus Cognitive Battery, a standard outcome measure for clinical trials to assess the impact of new interventions on core cognitive deficits in schizophrenia. Dr. Nuechterlein is currently the president of the Society for Research in Psychopathology.

Research Participants
Copyright © 2005- 2016 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright